The document will explain the expectations of each phase of an SBIR/STTR award
The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
GLP-1 related hair loss is predominantly telogen effluvium, which is a temporary and self-resolving condition
However, there are several specific reasons why you might feel less than optimal
From tissue repair to anti-inflammatory effects, this peptide seems to hold the key to accelerated recovery and enhanced well-being
This peptide has gained attention for its ability to help reduce inflammation and support the immune system